11-58507798-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005218.3(OR5B21):āc.308T>Gā(p.Val103Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000229 in 1,613,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5B21 | NM_001005218.3 | c.308T>G | p.Val103Gly | missense_variant | 1/1 | ENST00000360374.3 | NP_001005218.1 | |
LOC105369313 | XR_007062673.1 | n.239-2256T>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5B21 | ENST00000360374.3 | c.308T>G | p.Val103Gly | missense_variant | 1/1 | 6 | NM_001005218.3 | ENSP00000353537.2 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250426Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135298
GnomAD4 exome AF: 0.000224 AC: 328AN: 1461758Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 156AN XY: 727154
GnomAD4 genome AF: 0.000269 AC: 41AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74388
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 07, 2023 | The c.308T>G (p.V103G) alteration is located in exon 1 (coding exon 1) of the OR5B21 gene. This alteration results from a T to G substitution at nucleotide position 308, causing the valine (V) at amino acid position 103 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at